title: Column selection for pharmaceutical analyses based on a column classification using four test parameters.
abstract: This paper focuses on the usability of a previously developed column classification system, applied to pharmaceutical analyses. The separation of two drugs from their respective related substances was investigated on 65 new reversed-phase liquid chromatographic columns. The chromatographic procedure for fluoxetine hydrochloride was performed according to the method prescribed in the European Pharmacopoeia monograph while the separation of gemcitabine hydrochloride was carried out according to the United States Pharmacopeia monograph. It was shown that the column ranking system is a helpful tool in the selection of a suitable column.
authors.affiliation: Katholieke Universiteit Leuven, Laboratorium voor Farmaceutische Analyse, Onderzoek en Navorsing 2, Herestraat 49, B-3000 Leuven, Belgium.
authors.forename: Kristóf
authors.initials: K
authors.lastname: Kóczián
authors.forename: Erik
authors.initials: E
authors.lastname: Haghedooren
authors.forename: Sanja
authors.initials: S
authors.lastname: Dragovic
authors.forename: Béla
authors.initials: B
authors.lastname: Noszál
authors.forename: Jos
authors.initials: J
authors.lastname: Hoogmartens
authors.forename: Erwin
authors.initials: E
authors.lastname: Adams
mesh_terms: D015082:2,2'-Dipyridyl / Q000032:analysis; D018687:Antidepressive Agents, Second-Generation / Q000032:analysis; D000964:Antimetabolites, Antineoplastic / Q000032:analysis; D002853:Chromatography, Liquid / Q000145:classification* / Q000295:instrumentation*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000032:analysis; D005060:Europe; D005473:Fluoxetine / Q000031:analogs & derivatives / Q000032:analysis; D007202:Indicators and Reagents; D010316:Particle Size; D004364:Pharmaceutical Preparations / Q000032:analysis*; D010602:Pharmacopoeias as Topic; D016062:Porosity; D012997:Solvents; D014481:United States; D000093542:Gemcitabine
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000964:Antimetabolites, Antineoplastic; D007202:Indicators and Reagents; D004364:Pharmaceutical Preparations; D012997:Solvents; D005473:Fluoxetine; D003841:Deoxycytidine; D015082:2,2'-Dipyridyl; D000093542:Gemcitabine